Blastocystosis is a gastrointestinal infection caused by the protozoan parasite Blastocystis hominis. This single-celled organism is commonly found in contaminated water and food, making it a prevalent cause of intestinal infections in humans. The clinical presentation of blastocystosis varies widely, with some individuals remaining asymptomatic while others experience symptoms such as abdominal pain, diarrhea, bloating, and nausea. The transmission of Blastocystis hominis occurs through the ingestion of cysts, which are the dormant and infective stage of the parasite. Risk factors for infection include poor sanitation, consumption of contaminated water or food, and close contact with infected individuals. Diagnosis of blastocystosis involves the identification of Blastocystis hominis cysts or trophozoites in stool samples. However, the interpretation of diagnostic results can be challenging due to the variable clinical significance of the parasite. In some cases, Blastocystis hominis is considered a commensal organism, while in others, it may contribute to gastrointestinal symptoms. Treatment options for symptomatic cases often involve antimicrobial agents, such as metronidazole or other antiprotozoal medications. However, controversies surround the interpretation of treatment efficacy, as some individuals may continue to harbor the parasite despite clinical resolution.
Title : Extensively drug-resistant bacterial infections: Confronting a global crisis with urgent solutions in prevention, surveillance, and treatment
Yazdan Mirzanejad, University of British Columbia, Canada
Title : Pathogen-derived noncanonical epitopes: Are they valuable targets for novel vaccinations and shall we be concerned about autoimmune responses?
Michele Mishto, Francis Crick Institute, United Kingdom
Title : Bioterrorism through the ages: Historical perspective, emerging threats, and medical countermeasures
Claudia Ferreira, Sorbonne University, France
Title : When acute EBV mimics HIV: A case of false positive p24 antigen and low-level HIV antibody reactivity
Smriti Chaudhary, Imperial College Healthcare NHS Trust, United Kingdom
Title : OnePeru: Peruvian bioinformatics platform to contribute to the fight against antimicrobial resistance
Pool Marcos Carbajal, University of San Martin de Porres, Peru
Title : Measles vaccination coverage indicators in 2023 and advance towards measles elimination and eradication by 2030
Pedro Plans Rubio, College of Physicians of Barcelona, Spain